FRANKLIN RESOURCES INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 63 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$440,910
-38.3%
13,944
-20.4%
0.00%
Q2 2023$714,099
+94.1%
17,511
+77.4%
0.00%
Q1 2023$367,818
-2.3%
9,869
-8.5%
0.00%
Q4 2022$376,464
-36.0%
10,790
+2.8%
0.00%
Q3 2022$588,000
-97.6%
10,492
-97.8%
0.00%
-100.0%
Q2 2022$24,156,000
-65.6%
466,673
-51.7%
0.01%
-57.1%
Q1 2022$70,245,000
-47.4%
966,638
-14.4%
0.03%
-41.7%
Q4 2021$133,562,000
+1.7%
1,129,581
+15.3%
0.05%
-2.0%
Q3 2021$131,393,000
+108.0%
979,450
+151.0%
0.05%
+104.2%
Q2 2021$63,169,000
+5787.1%
390,148
+2815.7%
0.02%
Q1 2021$1,073,000
+135.8%
13,381
+59.7%
0.00%
Q4 2020$455,000
-89.2%
8,377
-97.2%
0.00%
-100.0%
Q1 2017$4,227,000
+7.5%
300,0000.0%0.00%0.0%
Q4 2016$3,933,000
-23.0%
300,0000.0%0.00%
-33.3%
Q3 2016$5,106,000
-20.3%
300,0000.0%0.00%0.0%
Q2 2016$6,405,000300,0000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders